Vascular phenotype identification and anti-angiogenic treatment recommendation: A pseudo-multiscale mathematical model of angiogenesis

The development of anti-angiogenic drugs for cancer therapy has yielded some promising candidates, but novel approaches for interventions to angiogenesis have led to disappointing results. In addition, there is a shortage of biomarkers that are predictive of response to anti-angiogenic treatments. C...

Full description

Bibliographic Details
Main Authors: Hutchinson, LG, Gaffney, EA, Maini, PK, Wagg, J, Phipps, A, Byrne, HM
Format: Journal article
Language:English
Published: Elsevier 2016
_version_ 1797111663698116608
author Hutchinson, LG
Gaffney, EA
Maini, PK
Wagg, J
Phipps, A
Byrne, HM
author_facet Hutchinson, LG
Gaffney, EA
Maini, PK
Wagg, J
Phipps, A
Byrne, HM
author_sort Hutchinson, LG
collection OXFORD
description The development of anti-angiogenic drugs for cancer therapy has yielded some promising candidates, but novel approaches for interventions to angiogenesis have led to disappointing results. In addition, there is a shortage of biomarkers that are predictive of response to anti-angiogenic treatments. Consequently, the complex biochemical and physiological basis for tumour angiogenesis remains incompletely understood. We have adopted a mathematical approach to address these issues, formulating a spatially averaged multiscale model that couples the dynamics of VEGF, Ang1, Ang2 and PDGF, with those of mature and immature endothelial cells and pericyte cells. The model reproduces qualitative experimental results regarding pericyte coverage of vessels after treatment by anti-Ang2, anti-VEGF and combination anti-VEGF/anti-Ang2 antibodies. We used the steady state behaviours of the model to characterise angiogenic and non-angiogenic vascular phenotypes, and used mechanistic perturbations representing hypothetical anti-angiogenic treatments to generate testable hypotheses regarding transitions to non-angiogenic phenotypes that depend on the pre-treatment vascular phenotype. Additionally, we predicted a synergistic effect between anti-VEGF and anti-Ang2 treatments when applied to an immature pre-treatment vascular phenotype, but not when applied to a normalised angiogenic pre-treatment phenotype. Based on these findings, we conclude that changes in vascular phenotype are predicted to be useful as an experimental biomarker of response to treatment. Further, our analysis illustrates the potential value of non-spatial mathematical models for generating tractable predictions regarding the action of anti-angiogenic therapies.
first_indexed 2024-03-07T08:13:35Z
format Journal article
id oxford-uuid:0fa35a82-1121-47e2-a586-ae27b9faf1aa
institution University of Oxford
language English
last_indexed 2024-03-07T08:13:35Z
publishDate 2016
publisher Elsevier
record_format dspace
spelling oxford-uuid:0fa35a82-1121-47e2-a586-ae27b9faf1aa2023-12-13T10:42:22ZVascular phenotype identification and anti-angiogenic treatment recommendation: A pseudo-multiscale mathematical model of angiogenesisJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:0fa35a82-1121-47e2-a586-ae27b9faf1aaEnglishSymplectic Elements at OxfordElsevier2016Hutchinson, LGGaffney, EAMaini, PKWagg, JPhipps, AByrne, HMThe development of anti-angiogenic drugs for cancer therapy has yielded some promising candidates, but novel approaches for interventions to angiogenesis have led to disappointing results. In addition, there is a shortage of biomarkers that are predictive of response to anti-angiogenic treatments. Consequently, the complex biochemical and physiological basis for tumour angiogenesis remains incompletely understood. We have adopted a mathematical approach to address these issues, formulating a spatially averaged multiscale model that couples the dynamics of VEGF, Ang1, Ang2 and PDGF, with those of mature and immature endothelial cells and pericyte cells. The model reproduces qualitative experimental results regarding pericyte coverage of vessels after treatment by anti-Ang2, anti-VEGF and combination anti-VEGF/anti-Ang2 antibodies. We used the steady state behaviours of the model to characterise angiogenic and non-angiogenic vascular phenotypes, and used mechanistic perturbations representing hypothetical anti-angiogenic treatments to generate testable hypotheses regarding transitions to non-angiogenic phenotypes that depend on the pre-treatment vascular phenotype. Additionally, we predicted a synergistic effect between anti-VEGF and anti-Ang2 treatments when applied to an immature pre-treatment vascular phenotype, but not when applied to a normalised angiogenic pre-treatment phenotype. Based on these findings, we conclude that changes in vascular phenotype are predicted to be useful as an experimental biomarker of response to treatment. Further, our analysis illustrates the potential value of non-spatial mathematical models for generating tractable predictions regarding the action of anti-angiogenic therapies.
spellingShingle Hutchinson, LG
Gaffney, EA
Maini, PK
Wagg, J
Phipps, A
Byrne, HM
Vascular phenotype identification and anti-angiogenic treatment recommendation: A pseudo-multiscale mathematical model of angiogenesis
title Vascular phenotype identification and anti-angiogenic treatment recommendation: A pseudo-multiscale mathematical model of angiogenesis
title_full Vascular phenotype identification and anti-angiogenic treatment recommendation: A pseudo-multiscale mathematical model of angiogenesis
title_fullStr Vascular phenotype identification and anti-angiogenic treatment recommendation: A pseudo-multiscale mathematical model of angiogenesis
title_full_unstemmed Vascular phenotype identification and anti-angiogenic treatment recommendation: A pseudo-multiscale mathematical model of angiogenesis
title_short Vascular phenotype identification and anti-angiogenic treatment recommendation: A pseudo-multiscale mathematical model of angiogenesis
title_sort vascular phenotype identification and anti angiogenic treatment recommendation a pseudo multiscale mathematical model of angiogenesis
work_keys_str_mv AT hutchinsonlg vascularphenotypeidentificationandantiangiogenictreatmentrecommendationapseudomultiscalemathematicalmodelofangiogenesis
AT gaffneyea vascularphenotypeidentificationandantiangiogenictreatmentrecommendationapseudomultiscalemathematicalmodelofangiogenesis
AT mainipk vascularphenotypeidentificationandantiangiogenictreatmentrecommendationapseudomultiscalemathematicalmodelofangiogenesis
AT waggj vascularphenotypeidentificationandantiangiogenictreatmentrecommendationapseudomultiscalemathematicalmodelofangiogenesis
AT phippsa vascularphenotypeidentificationandantiangiogenictreatmentrecommendationapseudomultiscalemathematicalmodelofangiogenesis
AT byrnehm vascularphenotypeidentificationandantiangiogenictreatmentrecommendationapseudomultiscalemathematicalmodelofangiogenesis